Neu1 Antibodies

Santa Cruz Biotechnology features a diverse variety of Neu1 monoclonal antibodies for investigating neuraminidase 1 (Neu1) in various biological processes. Neu1 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Neuraminidase 1 functions as an enzyme responsible for removing sialic acid residues from glycoproteins and glycolipids, playing a crucial role in cellular signaling, immune response, and pathogen recognition. Neu1 dysregulation has been linked to various diseases, including cancer and neurodegenerative disorders, highlighting its importance as a therapeutic target. Research utilizing Neu1 monoclonal antibodies can reveal essential insights into cellular mechanisms and disease pathways. Investigating Neu1 activity and expression patterns helps researchers better understand its role in health and disease. Exploring Neu1 function through detailed molecular studies may uncover new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for Neu1 enable researchers worldwide to advance scientific understanding and potentially develop new therapeutic approaches.